Research into Stage iv breast cancer ajcc v6 and v7 spans multiple therapeutic approaches and trial phases.

10 total trials for this combination

Trials

NCT ID	Title	Status	Phase
NCT03633331	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer	COMPLETED	—
NCT00785291	Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	COMPLETED	PHASE3
NCT00699491	Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer	COMPLETED	PHASE1/PHASE2
NCT02311933	Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer	ACTIVE_NOT_RECRUITING	—
NCT00601900	Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer	COMPLETED	PHASE3
NCT00390455	Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive	COMPLETED	PHASE3
NCT03199885	Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer	COMPLETED	PHASE3
NCT02595905	Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases	COMPLETED	PHASE2
NCT03418961	S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity	RECRUITING	PHASE3
NCT05334069	Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection	RECRUITING	—

Related Pages

All Stage iv breast cancer ajcc v6 and v7 trials All trials in Kewanee, United States